MMP9 and malignant mesothelioma: Significantly, Nasu and colleagues demonstrated that ONC is a potent inhibitor of NF-κB activity in malignant mesothelioma, suggesting that the ONC blockage of NF-κB activation leads to the inhibition of MMP9 secretion and of its consequent invasiveness [28].